Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2012; 137(48): 2499
DOI: 10.1055/s-0032-1327302
DOI: 10.1055/s-0032-1327302
Pro & Contra | Commentary
Hypertensiologie
Duale RAS-Blockade in der antihypertensiven Therapie – contra
Dual blockade of the renin-angiotensin system in hypertensive treatment: noFurther Information
Publication History
Publication Date:
20 November 2012 (online)
-
Literatur
- 1 Parving HH, Brenner BM, McMurray JJ et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med 2012; DOI: 10.1056/NEJMoa1208799.
- 2 Yusuf S, Teo KK, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-1559